Showing results (1181-1190 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|May 16, 2017
Severe traumatic brain injury: targeted management in the intensive care unitNino Stocchetti, Marco Carbonara, Giuseppe Citerio, et al.
The Lancet. Neurology|May 16, 2017
Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate?Richard L Doty
The Lancet. Neurology|April 28, 2018
Risk factors for non-motor symptoms in Parkinson's diseaseJohan Marinus, Kangdi Zhu, Connie Marras, et al.
The Lancet. Neurology|June 12, 2018
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing studyMarialuisa Quadri, Wim Mandemakers, Martyna M Grochowska, et al.
The Lancet. Neurology|June 12, 2018
Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysisSara Mazzucco, Linxin Li, Lucy Binney, et al.
The Lancet. Neurology|June 20, 2018
Network imaging biomarkers: insights and clinical applications in Parkinson's diseaseKatharina A Schindlbeck, David Eidelberg
The Lancet. Neurology|June 20, 2018
Sex differences in the evaluation and treatment of acute ischaemic strokeCheryl Bushnell, Virginia J Howard, Lynda Lisabeth, et al.
The Lancet. Neurology|May 28, 2019
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studiesDuncan Wilson, Gareth Ambler, Keon-Joo Lee, et al.
The Lancet. Neurology|September 29, 2018
The hippocampus in multiple sclerosisMaria A Rocca, Frederik Barkhof, John De Luca, et al.
The Lancet. Neurology|October 3, 2018
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trialScott E Kasner, Balakumar Swaminathan, Pablo Lavados, et al.
Pageof 199